EpiVax receives $458,000 NIH grant to develop universal influenza vaccine

PROVIDENCE – EpiVax Inc. said Tuesday it has received a $458,000, two-year grant to develop a universal influenza vaccine. “There is an urgent, unmet need for an influenza vaccine with greater potency and wider application to diverse flu viruses that can also be developed more rapidly than conventional influenza vaccines,” said Dr. Annie De Groot,…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display